SPC Life Sciences IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Apr 24, 2023Let’s have a detailed review of the company and analytics of the SPC Life Sciences IPO release date, IPO offer price, subscription, SPC Life Sciences Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 10 |
| Price Band | Rs [●] |
| Listing At | BSE, NSE |
| Min. Order Quantity | NA Shares |
| Listing Date | NA |
| Offer for Sale | Rs Million |
| Fresh Issue | Rs 3,000 Million |
| IPO Size | Rs Million |
| Tick Size | 1 |
SPC Life Sciences IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
| Live Performance – SPC Life Sciences Share Price |
SPC Life Sciences IPO – Summary
They are one of India’s leading manufacturers of advanced intermediates for certain key active pharmaceutical ingredients (“APIs”), including Pentoxifylline, AmiodaroneHCL, Cilostazol, Trazodone, Tramadol and Paroxetine.
Also, they are a research and development(“R&D”)driven chemical manufacturing company focused on chemistries involving long-chain multi-stage reactions. So, the advanced pharmaceutical intermediates (“Pharma Intermediates”) which are manufactured by them are used in certain growing therapeutic areas.
The Promoter of this company is SNEHAL RAVJIBHAI PATEL. The lead manager of the issue is Ambit Private Limited and HDFC Bank Limited, and the Registrar of this issue is Link Intime India Private Limited.
SPC Life Sciences IPO Date
The opening and closing dates of the SPC Life Sciences IPO are not available yet.
SPC Life Sciences IPO Subscription
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – | ||||
| 2nd Day – | ||||
| 3rd Day – | ||||
| Shares Offered or Net Issue |
The shares subscribed by the public will be updated here.
SPC Life Sciences IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares are pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
SPC Life Sciences Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | – |
| Refunds Initiation | – |
| Credit of Shares to Demat Account | – |
| Share Listing Date | – |
SPC Life Sciences IPO Price Band
The face value of each share is Rs.10, but the price band of the IPO is Rs.[●]
SPC Life Sciences IPO Equity Size
This Initial Public Issue of 8,938,870 Equity Shares of Rs.10 each for cash at a price of Rs.[●] per equity share aggregating to Rs.[●] Million.
SPC Life Sciences IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 8,938,870 Equity Shares of Rs.10/ each.
Issue Size: 8,938,870 Equity Shares of Rs.10 each, aggregating to Rs.[●] Million
Open Free Demat Account Now!
SPC Life Sciences IPO – Live Performance
The listing date of this IPO is [●]. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – SPC Life Sciences Share Price |
SPC Life Sciences IPO Grey Market Premium
The SPC Life Sciences Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is Rs X.
SPC Life Sciences IPO – Company Overview
Their Company is the world’s largest manufacturer of 6-Chloro-Hexane-2-One (an intermediate for cardiovascular (hemorheological) drug Pentoxifylline) in Fiscal 2022 with a 93% market share.
They are the only supplier of 2-N-Butyl-3-(3,5-Diiodo-4-Hydroxy Benzoyl) Benzofuran (which is a key structural component of Amiodarone HCL) and associated sub-products in India with 20% global market share in Fiscal 2022.
Also, their Company is a manufacturer of 2-Di Ethyl Amino Ethyl Chloride Hydrochloride (which is also a key structural component of Amiodarone HCL)with 13%global market share in Fiscal 2022.
Such intermediates manufactured by their Company (which are used in the manufacturing of Amiodarone HCL) are categorised as import substitutes.
SPC Life Sciences IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Million) | |||||
| 30-Sep-22 | 30-Sep-21 |
Mar-22 | 31-Mar-21 | 31-Mar-20 | |
| Total Assets |
1,694.16
|
1,151.88
|
1,380.68
|
1,028.17
|
779.13
|
| *Total Revenue |
885.18
|
701.53
|
1,464.42
|
1,361.42
|
1,210.99 |
| Total Expense |
747.64
|
569.91
|
1,205.63
|
1,139.24
|
1,069.24
|
| Profit After Tax |
101.13
|
98.70
|
192.33
|
166.70
|
103.83
|
Earnings per Equity Share (in Million)
| 30-Sep-22 | 30-Sep-21 |
Mar-22 | 31-Mar-21 | 31-Mar-20 | |
| Basic & Diluted | 2.26 | 2.21 | 4.30 |
3.73
|
2.32
|
Further, their PAT for the period ended on Sep 30, 2022, Sep 30, 2021, March 31, 2022, March 31, 2021, and March 31, 2020, were Rs. 101.13 Million, Rs. 98.70 Million, Rs. 192.33 Million, Rs. 166.70 Million and Rs. 103.83 Million respectively.
SPC Life Sciences IPO – Promoters
The Promoter of this company is:
- SNEHAL RAVJIBHAI PATEL
List of Related Parties (Key Managerial Personnel)
-
Snehal Ravjibhai Patel, Managing Director
-
Ravjibhai Dudabhai Dudhat, Whole-time Director
-
Mili Snehal Patel, Whole-time Director
-
Kiran Kumar Shah, Independent Director
- Maulik Chandraketu Mehta, Independent Director
SPC Life Sciences IPO – Promoters Holding
- Pre-Issue Share Holding – %
- Post-Issue Share Holding – %
SPC Life Sciences IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to X Equity Shares aggregating up to Rs.[●] Million |
| of which: | |
| Issue Reserved for the Market Makers | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Net Issue to the Public | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Of which: | |
| Retail Investors Portion | Not less than [●] Equity Shares |
| Other than Retail Individual Investors | Not more than [●] Equity Shares |
| Equity Shares outstanding prior to the Issue | 44,694,352 Equity Shares |
| Equity Shares outstanding after the Issue | X Equity Shares |
SPC Life Sciences IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
1. Re-payment/Prepayment of certain outstanding borrowings availed by their Company;
2. Funding of capital expenditure requirements of their Company towards setting up Phase-2 at their Dahej Facility to expand their product offerings of pharmaceutical intermediates;
3. Funding their working capital requirements; and
4. General corporate purposes
SPC Life Sciences IPO – Business Strategy
- Expand their business by capitalizing on industry opportunities on multiple fronts
- Optimize utilization of recently commissioned Dahej Phase–1 facility and draw benefits of backward integration
- Focus on maximizing their presence across multiple chemistry value chains
SPC Life Sciences IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- A strong and diversified portfolio of Pharma Intermediates and KSMs catering to growing therapeutic areas;
- Diversified customer base with long-standing relationships across multiple geographies;
- Research and development focused company, specialized in chemistries involving long chain multi-stage reactions;
- High entry barriers due to the complex manufacturing processes, long customer approval cycles and strict compliance requirements;
- Focus on quality, environment, health and safety;
- Strong sales and marketing capabilities; and
- Experienced leadership team with technocrat Promoter and strong corporate governance
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-22 |
4.30
|
28.00 | 61.48 |
| 31-Mar-21 | 3.73 | 33.80 | – |
| Mar-20 |
2.32
|
31.82 | – |
SPC Life Sciences IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Million) | |
| SPC Life Sciences Limited | 10 | [●] |
4.30
|
28.00 | 1,464.42 |
| Listed Peers | |||||
| Aarti Industries | 5 |
13.75
|
36.06
|
22.10
|
70,007.60
|
| Ami Organics | 10 |
42.64
|
21.03
|
13.78
|
5,228.97
|
|
Neogen Chemicals
|
10 |
68.80
|
18.70
|
10.16
|
4,883.20
|
SPC Life Sciences IPO Lead Managers
| Lead Managers |
|
Ambit Private Limited HDFC Bank Limited |
SPC Life Sciences IPO Registrar to offer
| Registrar to the Offer |
| Link Intime India Private Limited C-101, 1st Floor, 247 Park, L.B.S. Marg Vikhroli West, Mumbai 400 083 Maharashtra, India Telephone: +91 810 811 4949 Email: spclifesciences.ipo@linkintime.co.in Investor Grievance E-mail:spclifesciences.ipo@linkintime.co.in Website:www.linkintime.co.in Contact person: Shanti Gopalkrishnan SEBI registration number: INR000004058 |
SPC Life Sciences IPO – Other Details
- Statutory Auditor – CNK and Associates LLP, Chartered Accountants
- Legal Counsel to the Company – J. Sagar Associates
- Bankers to the Company – HDFC Bank Limited and State Bank of India
SPC Life Sciences IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to SPC Life Sciences IPO
SPC Life Sciences Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
SPC Life Sciences IPO Review FAQs
Check out various FAQs related to SPC Life Sciences IPO:
What is the Issue Size of SPC Life Sciences IPO?
The Company is making an initial public offer of 8,938,870 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of SPC Life Sciences IPO?
The price band for this particular IPO ranges between Rs NA. As far as the face value of the share is of concern, it is Rs. NA per share.
What is the SPC Life Sciences IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.
What is the SPC Life Sciences IPO Allotment Date?
They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.
What is the SPC Life IPO Listing Date?
Shares of this company shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.
Who is the Registrar of SPC Life IPO?
One of the reputed registrars is managing the issue of this IPO, i.e. Link Intime India Private Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of SPC Life IPO?
Here are the promoters of this IPO – SNEHAL RAVJIBHAI PATEL. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of SPC Life IPO?
They have obtained the GMP of this IPO and it is Rs NA. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.
Is SPC Life IPO Good for Investment?
They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of SPC Life Company?
They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2022 in Million is 192.33, 2021 is 166.70, and 2020 is 103.83. PAT from Sep 2022 is 101.13.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics